Finance · Corrected
Merck Quarterly Sales Rise 5% to $18.1 Billion
Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources
Brief
Merck & Co. earned an adjusted $2.49 a share in the third quarter.
Keep reading with NewsPlain Premium
Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.
2 sources behind this story.
Updates
Correction, : Correction: The approximately $550 million benefit from purchase timing applied to pharmaceutical sales across the portfolio, rather than Winrevair alone.